{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T08:02:42Z","timestamp":1780905762925,"version":"3.54.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T00:00:00Z","timestamp":1712275200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.ijrobp.2024.03.045","type":"journal-article","created":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T18:39:02Z","timestamp":1712342342000},"page":"332-342","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Evaluation of Radiation Therapy Treatment Plans in a Randomized Phase 2 Trial Comparing 2 Schedules of Twice-Daily Thoracic Radiation Therapy in Limited Stage Small Cell Lung Cancer"],"prefix":"10.1016","volume":"120","author":[{"given":"Nina","family":"Levin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin T.","family":"Killingberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarje O.","family":"Halvorsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Signe","family":"Danielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f8rn Henning","family":"Gr\u00f8nberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2024.03.045_bib0001","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/S1470-2045(23)00444-8","article-title":"Global variations in lung cancer incidence by histological subtype in 2020: A population-based study","volume":"24","author":"Zhang","year":"2023","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2024.03.045_bib0002","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1200\/JCO.21.01639","article-title":"Radiation and systemic therapy for limited-stage small-cell lung cancer","volume":"40","author":"Bogart","year":"2022","journal-title":"J Clin Oncol"},{"issue":"16 Suppl","key":"10.1016\/j.ijrobp.2024.03.045_bib0003","doi-asserted-by":"crossref","first-page":"8512","DOI":"10.1200\/JCO.2023.41.16_suppl.8512","article-title":"Final survival data from a randomized phase II trial comparing high-dose with standard-dose twice-daily (BID) thoracic radiotherapy (TRT) in limited stage small-cell lung cancer (LS SCLC)","volume":"41","author":"Gr\u00f8nberg","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2024.03.045_bib0004","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1200\/JCO.22.01359","article-title":"High-dose once-daily thoracic radiotherapy in limited-stage small-cell lung cancer: CALGB 30610 (Alliance)\/RTOG 0538","volume":"41","author":"Bogart","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2024.03.045_bib0005","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/S1470-2045(17)30318-2","article-title":"Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): An open-label, phase 3, randomised, superiority trial","volume":"18","author":"Faivre-Finn","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2024.03.045_bib0006","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1056\/NEJM199901283400403","article-title":"Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide","volume":"340","author":"Turrisi 3rd","year":"1999","journal-title":"New Engl J Med"},{"key":"10.1016\/j.ijrobp.2024.03.045_bib0007","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.annonc.2021.03.207","article-title":"Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"32","author":"Dingemans","year":"2021","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2024.03.045_bib0008","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1200\/JCO.20.03364","article-title":"Radiation therapy for small-cell lung cancer: ASCO guideline endorsement of an ASTRO guideline","volume":"39","author":"Daly","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2024.03.045_bib0009","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.prro.2020.02.009","article-title":"Radiation therapy for small cell lung cancer: An ASTRO clinical practice guideline","volume":"10","author":"Simone 2nd","year":"2020","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2024.03.045_bib0010","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jtho.2020.10.020","article-title":"American Radium Society appropriate use criteria: Radiation therapy for limited-stage SCLC 2020","volume":"16","author":"Chun","year":"2021","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ijrobp.2024.03.045_bib0011","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.lungcan.2019.08.007","article-title":"Current management of limited-stage SCLC and CONVERT trial impact: Results of the EORTC Lung Cancer Group survey","volume":"136","author":"Levy","year":"2019","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ijrobp.2024.03.045_bib0012","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cllc.2018.08.015","article-title":"Radiation dose and fractionation for limited-stage small-cell lung cancer: Survey of US radiation oncologists on practice patterns","volume":"20","author":"Farrell","year":"2019","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.ijrobp.2024.03.045_bib0013","article-title":"Practice patterns of treatment strategy of limited-stage small-cell lung cancer: Survey of Chinese oncologists","volume":"12","author":"Xu","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2024.03.045_bib0014","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1470-2045(20)30742-7","article-title":"High-dose versus standard-dose twice-daily thoracic radiotherapy for patients with limited stage small-cell lung cancer: An open-label, randomised, phase 2 trial","volume":"22","author":"Gr\u00f8nberg","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2024.03.045_bib0015","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0169-5002(89)90156-6","article-title":"Staging and prognostic factors in small cell lung cancer: a consensus report","volume":"5","author":"Stahel","year":"1989","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ijrobp.2024.03.045_bib0016","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.radonc.2022.05.018","article-title":"Training, validation, and clinical implementation of a deep-learning segmentation model for radiotherapy of loco-regional breast cancer","volume":"173","author":"Almberg","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2024.03.045_bib0017","first-page":"1","article-title":"Report 83: Prescribing, Recording, and Reporting Photon-Beam Intensity-Modulated Radiation Therapy (IMRT)","volume":"10","year":"2010","journal-title":"Journal of the ICRU"},{"key":"10.1016\/j.ijrobp.2024.03.045_bib0018","doi-asserted-by":"crossref","first-page":"591","DOI":"10.3109\/0284186X.2015.1092584","article-title":"Randomized phase II trial comparing twice daily hyperfractionated with once daily hypofractionated thoracic radiotherapy in limited disease small cell lung cancer","volume":"55","author":"Gr\u00f8nberg","year":"2016","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ijrobp.2024.03.045_bib0019","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.ijrobp.2021.05.003","article-title":"Moderately hypofractionated once-daily compared with twice-daily thoracic radiation therapy concurrently with etoposide and cisplatin in limited-stage small cell lung cancer: A multicenter, phase II, randomized trial","volume":"111","author":"Qiu","year":"2021","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2024.03.045_bib0020","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00408-013-9518-9","article-title":"Comparison of once and twice daily radiotherapy for limited stage small-cell lung cancer","volume":"192","author":"Gazula","year":"2014","journal-title":"Lung"},{"key":"10.1016\/j.ijrobp.2024.03.045_bib0021","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1080\/02841860701316065","article-title":"Accelerated hyperfractionated radiotherapy and concomitant chemotherapy in small cell lung cancer limited-disease. Dose response, feasibility and outcome for patients treated in western Sweden, 1998-2004","volume":"46","author":"Hallqvist","year":"2007","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ijrobp.2024.03.045_bib0022","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/1759-7714.12262","article-title":"Comparison of once daily radiotherapy to 60 Gy and twice daily radiotherapy to 45 Gy for limited stage small-cell lung cancer","volume":"6","author":"Han","year":"2015","journal-title":"Thorac Cancer"},{"key":"10.1016\/j.ijrobp.2024.03.045_bib0023","article-title":"Association between radiotherapy protocol variations and outcome in the CONVERT trial","volume":"39","author":"Mir","year":"2023","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2024.03.045_bib0024","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-009849","volume":"6","author":"Faivre-Finn","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.ijrobp.2024.03.045_bib0025","unstructured":"Alliance for Clinical Trials in Oncology. Protocol: Phase III comparison of thoracic radiotherapy regimens in patients with limited small cell lung cancer also receiving cisplatin or carboplatin and etoposide (Update #14, March 15, 2008). Identifier: NCT00632853: US National Library of Medicine; 2008. Accessed October 26, 2023. https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT00632853"},{"issue":"3 Suppl","key":"10.1016\/j.ijrobp.2024.03.045_bib0026","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/j.ijrobp.2009.04.095","article-title":"Radiation dose-volume effects in the spinal cord","volume":"76","author":"Kirkpatrick","year":"2010","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2024.03.045_bib0027","article-title":"Incidence and treatment outcome of radiation pneumonitis in patients with limited-stage small cell lung cancer treated with concurrent accelerated hyperfractionated radiation therapy and chemotherapy","volume":"8","author":"Doshita","year":"2023","journal-title":"Adv Radiat Oncol"},{"issue":"3 Suppl","key":"10.1016\/j.ijrobp.2024.03.045_bib0028","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1016\/j.ijrobp.2009.04.093","article-title":"Radiation dose-volume effects in the heart","volume":"76","author":"Gagliardi","year":"2010","journal-title":"Int J Radiat Oncol"},{"issue":"Suppl 3","key":"10.1016\/j.ijrobp.2024.03.045_bib0029","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1016\/j.ijrobp.2009.06.091","article-title":"Radiation dose\u2013volume effects in the lung","volume":"76","author":"Marks","year":"2010","journal-title":"Int J Radiat Oncol"},{"issue":"3 Suppl","key":"10.1016\/j.ijrobp.2024.03.045_bib0030","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1016\/j.ijrobp.2009.05.070","article-title":"Radiation dose-volume effects in the esophagus","volume":"76","author":"Werner-Wasik","year":"2010","journal-title":"Int J Radiat Oncol"},{"issue":"3 Suppl","key":"10.1016\/j.ijrobp.2024.03.045_bib0031","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.ijrobp.2009.07.1754","article-title":"Use of normal tissue complication probability models in the clinic","volume":"76","author":"Marks","year":"2010","journal-title":"Int J Radiat Oncol"}],"updated-by":[{"DOI":"10.1016\/j.ijrobp.2026.03.029","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T00:00:00Z","timestamp":1775174400000}},{"DOI":"10.1016\/j.ijrobp.2026.03.029","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000}}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301624004759?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301624004759?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T19:56:21Z","timestamp":1780862181000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301624004759"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S0360301624004759"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2024.03.045","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of Radiation Therapy Treatment Plans in a Randomized Phase 2 Trial Comparing 2 Schedules of Twice-Daily Thoracic Radiation Therapy in Limited Stage Small Cell Lung Cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2024.03.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}